Results 1 to 10 of about 4,284 (156)

Asymmetric Graves’ Orbitopathy [PDF]

open access: yesFrontiers in Endocrinology, 2020
Graves’ Orbitopathy (GO) is an autoimmune orbital disorder usually presenting as a sequala of autoimmune thyroid disease. The presence of GO is associated with increased psychological burden and, in severe cases may cause blindness.
Grigorios Panagiotou, Petros Perros
doaj   +4 more sources

Orbital Signaling in Graves’ Orbitopathy [PDF]

open access: yesFrontiers in Endocrinology, 2021
Graves’ orbitopathy (GO) is a complex and poorly understood disease in which extensive remodeling of orbital tissue is dominated by adipogenesis and hyaluronan production.
Mohd Shazli Draman   +4 more
doaj   +5 more sources

Graves’ Orbitopathy [PDF]

open access: yesInternational Journal of Endocrinology, 2015
Yuji Hiromatsu   +3 more
doaj   +4 more sources

Steroid-resistant Graves' orbitopathy: Therapeutic options [PDF]

open access: yesMedicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor", 2023
Graves orbitopathy is the most common extrathyroidal manifestation of autoimmune hyperthyroidism, although it can rarely occur in euthyroid and hypothyroid patients.
Klet Sanja   +6 more
doaj   +1 more source

Graves Orbitopathy

open access: yesMedicinska istrazivanja
Graves' orbitopathy (GO) represents eye changes that most often occur in patients with autoimmune hyperthyroidism-Graves' disease (GD), although they can also occur much less frequently in euthyroid and hypothyroid patients. About 30% of patients with Graves' disease have GO, while less than 10% develop a more severe form that requires treatment.
Fox TJ, Anastasopoulou C.
europepmc   +2 more sources

Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy

open access: yesFrontiers in Endocrinology, 2022
BackgroundImmunosuppressive therapy of Graves’ orbitopathy (GO) is indicated during the active phase of disease. Intravenous steroids (IVGC) are effective in about 70% of patients, although unresponsiveness or relapse are observed.
Irene Campi   +16 more
doaj   +1 more source

Pediatric Graves’ orbitopathy: a multicentre study [PDF]

open access: yesActa Ophthalmologica, 2021
AbstractPurposeGraves’ orbitopathy (GO) is a rare condition in children often considered to be a less severe condition than at an older age. The aim of our study was to analyse if there are any factors that distinguish paediatric from adult GO in order to provide guidelines for assessing and managing paediatric GO.MethodsStudy design is a multicentre ...
Ionescu, Ioana C   +10 more
openaire   +4 more sources

Graves’ Orbitopathy

open access: yesOphthalmology, 2007
Preface: Wiersinga, W.M. Kahaly, G.J. Diagnosis and Pathogenesis Clinical Manifestations: Dickinson, A.J. Orbit-Thyroid Relationship: Lazarus, J.H. Marino, M. Epidemiology: Daumerie, C. Kalmann, R. Pathogenesis: Orgiazzi, J. Orbital Imaging: Pitz, S. Diagnosis and Differential Diagnosis of Graves' Orbitopathy: Mourits, M.P.
Aparna, Bhatnagar   +4 more
openaire   +4 more sources

Microbiome and Graves’ Orbitopathy [PDF]

open access: yesEuropean Thyroid Journal, 2020
<b><i>Background:</i></b> Studies from animal models of autoimmunity have highlighted the potential importance of microorganisms and their metabolic products in shaping the immune system. <b><i>Summary:</i></b> This review provides an introduction to the current state-of-the-art in microbiome research ...
Giulia, Masetti, Marian, Ludgate
openaire   +2 more sources

Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature

open access: yesFrontiers in Endocrinology, 2017
IntroductionGraves’ orbitopathy is the extra thyroidal manifestation of Graves’ disease and the most common cause of exophthalmos. It is also known as thyroid-associated orbitopathy (TAO) as it occasionally occurs in euthyroid or hypothyroid patients ...
Neeraja Boddu   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy